IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
3.650
-0.010 (-0.27%)
At close: Jul 17, 2026, 4:00 PM EDT
3.640
-0.010 (-0.27%)
After-hours: Jul 17, 2026, 7:57 PM EDT
IceCure Medical Employees
As of December 31, 2025, IceCure Medical had 69 total employees, including 67 full-time and 2 part-time employees. The number of employees increased by 3 or 4.55% compared to the previous year.
Employees
69
Change (1Y)
3
Growth (1Y)
4.55%
Revenue / Employee
$51,667
Profits / Employee
-$228,159
Market Cap
12.51M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 69 | 3 | 4.55% | 67 | 2 |
| Dec 31, 2024 | 66 | -11 | -14.29% | 64 | 2 |
| Dec 31, 2023 | 77 | 5 | 6.94% | 71 | 6 |
| Dec 31, 2022 | 72 | 8 | 12.50% | 65 | 7 |
| Dec 31, 2021 | 64 | 17 | 36.17% | 55 | 9 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Trinity Biotech | 287 |
| Co-Diagnostics | 115 |
| IRIDEX | 93 |
| Lifeward | 81 |
| Picard Medical | 75 |
| VolitionRx | 67 |
| Modular Medical | 51 |
| Adagio Medical Holdings | 41 |
ICCM News
- 4 days ago - IceCure Medical expands U.S. commercial team for ProSense cryoablation - TheFly
- 4 days ago - IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation - PRNewsWire
- 4 days ago - IceCure Medical Slides: Investor presentation - Filings
- 12 days ago - IceCure Medical highlights expanding commercial adoption of ProSense - TheFly
- 12 days ago - IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer - PRNewsWire
- 23 days ago - IceCure Medical registers to sell 5.5M ordinary shares for holders - TheFly
- 23 days ago - IceCure Medical regains compliance with Nasdaq minimum bid price requirement - TheFly
- 23 days ago - IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement - PRNewsWire